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Abstract
Porcine circovirus type 2 (PCV-2) is the causal agent of the post-weaning multisystemic wasting syndrome (PMWS).
PCV-2 are small single-stranded circular DNA viruses clustered into two main genogroups: PCV-2a and PCV-2b. Each
genogroup present a specific highly-conserved motif of six amino acids (between amino acids 86 and 91) in the
PCV-2 capsid protein. The aim of this study was to verify whether the motif located in the capsid protein and
specific to each PCV-2 genogroup contributes to virulence. Two parental DNA clones, PCV-2a and PCV-2b, were
constructed as well as two mutants DNA clones, PCV-2a/motif 2b and PCV-2b/motif 2a by exchanging the capsid
motif of each genogroup. The four DNA clones were characterized in vitro as well as in vivo. Cells transfected by
the four DNA clones produced infectious viruses. In specific-pathogen-free piglets transfected by the four infectious
DNA clones, PCV-2b/motif 2a virulence was not attenuated while the PCV-2a/motif 2b virulence was drastically
reduced compared to their parent virulence. These results suggest that the amino acids between positions 86 and
91 of the capsid protein are determinant for the virulence of isolates. However, the environment of this motif
seems also involved.
Introduction
The first porcine circovirus (PCV) was discovered in a
pig kidney cell line (PK15 ATCC-CCL33) and was called
porcine circovirus type 1 (PCV-1) [1]. Experimental
infections have shown that PCV-1 is non-pathogenic for
pigs [2]. In the 1990s, a new disease called post-weaning
multisystemic wasting syndrome (PMWS) emerged in
Europe and North America. PMWS-affected animals
exhibit growth retardation, pallor and dyspnea. At
necropsy, lymph nodes are enlarged and the main histo-
logical lesions are lymphocyte depletion with histiocytic
inflammatory infiltration of lymphoid tissues [3]. A new
circovirus was identified from diseased pigs and was
named porcine circovirus type 2 (PCV-2) [4]. Now
PCV-2 is recognized as the etiological agent of PMWS
and is associated with several diseases designated by the
abbreviation PCVD (porcine circovirus-associated dis-
eases) [3]. To diagnose typical PMWS, specific clinical
signs and lesions have to be observed together with the
detection of PCV-2 antigen or nucleic acid in the lesions
[5]. Pigs infected experimentally often developed sub-
clinical infection and typical PMWS is hard to repro-
duce. Most experimental models used PCV-2 infection
combined with co-factors such as bacteria, virus or
immunostimulation to increase the severity of the clini-
cal signs and the incidence of PMWS [3]. Hence, to
qualify the PCV-2 virulence, the virulence definition
described by Casadevall et al. can be used [6]. The viru-
lence definition considered lesions and symptoms but
also which mechanism or step of viral life cycle is impli-
cated in the expression of virulence as ability to infect
the host or ability to replicate.
PCV-2 are small non-enveloped viruses, belonging to
the Circovirus genus of the Circoviridae family. Their
genome is a circular, single-stranded DNA molecule of
1767 or 1768 bases encoding three major open reading
frames (ORFs). ORF1 codes for the Rep and Rep’ proteins
implicated in the replication of the PCV-2 DNA [7].
ORF2 codes for the capsid protein (Cap) which is the
only structural protein [8] and ORF3 for a protein possi-
bly involved in apoptosis mechanism [9]. Molecular epi-
demiology studies allowed separating PCV-2 isolates into
two main genogroups: PCV-2a and PCV-2b [10,11].
PCV-2 isolates from each of the two major genogroups
had a motif, located between amino acids 86 to 91,
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[10]. In 2005, a PCVD outbreak occurred in North
America. This event was concomitant with the emer-
gence of isolates of PCV-2b genogroup [12], which hap-
pened also in some European countries including
Switzerland [13] and in Spain [14]. PCV-2b emergence
seemed to be correlated to PMWS outbreak, giving rise
to the assumption that the genogroup PCV-2b was more
virulent than the PCV-2a one. Nevertheless, no link was
clearly established between the genogroup and virulence
of isolates, because same isolates were detected in
PMWS-affected and non-affected herds in France [15].
The PCV-2 capsid protein is composed of 233 amino
acids and is about 30kDa [8]. Three- dimensional maps
from electron micrographs have shown that PCV-2 has
an icosahedral virus surface containing 60 capsid proteins
arranged in 12 pentamers and have a diameter of 20 nm
[16]. The capsid protein is the most variable protein in
the PCV-2 (91 to 100% of identity in nucleic acids versus
98 to 100% for the Rep). It is the main antigenic determi-
nant of PCV-2 and contains four linear B-cell epitopes.
These four immunodomains are enclosed between amino
acids 65 to 87, 113 to 139, 169 to 183 and the last one
between amino acids 230 and 234 [17,18], leading to this
protein being used for vaccine development.
A recent study demonstrated that the capsid protein
contained linear and also conformational epitopes. The
use of several monoclonal antibodies (mAbs) allowed
the PCV-2 isolates to be differentiated according to
their genogroup, PCV-2a or PCV-2b [19]. The specific
genogroup motif located in the capsid protein is par-
tially located in the first linear B epitope (amino acids
65 to 87), illustrating the importance of this capsid site
[10]. The capsid protein seemed to be a multifunctional
protein in the viral life cycle of PCV-2 as it is the only
one protein of viral capsid with the most important
variability and the main antigenic activity.
The aim of this study was to verify whether strains
representative of each PCV-2 genogroup differ in viru-
lence and whether the capsid motif, specific to the gen-
ogroup, is involved in PCV-2 virulence. Thus, we
produced four DNA clones; two parental clones repre-
s e n t a t i v eo fP C V - 2 aa n dP C V - 2 bg e n o g r o u p sa n dt w o
mutants generated by substitution of the motifs: PCV-2b
motif in the PCV-2a backbone (PCV-2a/motif 2b) and
PCV-2a motif in the backbone of PCV-2b (PCV-2b/motif
2a). The parental and mutant DNA clones were charac-
terized in vitro and in vivo to compare virulence.
Materials and methods
Cells and viruses
Porcine kidney PK15 cells (free of PCV-1 and PCV-2)
w e r eg r o w ni nE a g l e ’s Minimum Essential Medium
(Lonza, Levallois-Perret, France) supplemented with 5%
of fetal calf serum (FCS) and Penicillin and Streptomy-
cin (Gibco, Life technologies, Cergy-Pontoise, France),
the growth medium.
The PCV-2a virus used in this study was isolated from
at i s s u eh o m o g e n a t ec o n s t ituted of pulmonary, lymph
nodal and splenic tissues col l e c t e df r o mt wo pigs clini-
cally affected with PMWS [20]. The PCV-2b isolate
(GenBank accession number AF201311) came from lung
tissue collected from a conventional piglet showing
PMWS typical signs [21].
Constructions of PCV-2 parental infectious clones
In previous studies, PCV-2a and PCV-2b DNA clones
with 2 or 1.5 genome copies have already been con-
structed and characterized as infectious [21,22]. In this
study, parental DNA clones were constructed with a
copy of the PCV-2 genome (cap and rep genes) ligated
head-to-tail to another copy of the rep gene.
The construction of PCV-2a clone was carried out in
two stages. A long fragment corresponding to almost all
the PCV-2a was amplified by PCR from DNA extracted
from PCV-2a infected cells (see Table 1, PCV-2a long for-
ward and reverse primers). A second fragment corre-
sponding to the rep g e n eo ft h eP C V - 2 ag e n o m ew a s
a m p l i f i e db yP C Rw i t ht h eP C V - 2 as h o r tf o r w a r da n d
reverse primers (Table 1). For both fragment amplification,
the PCR mix included 0.2 mM of dNTP mix, 0.2 μMo f
each primer, 2 mM of MgSO4, 1 unit of Platinum Taq
Polymerase High Fidelity (Invitrogen, Carlsbad, CA, USA)
and its buffer to 1X in final concentration. The PCR pro-
gram for both reactions was composed of a first denatur-
ing step of 2 min at 94°C, then 30 amplification cycles
with one denaturing step of 30 s at 94°C, an annealing
step of 30 s at 56 and 54.5°C (respectively for the long and
short fragments) and an elongation step of 1.5 min at
72°C; and finally an elongation step of 10 min at 72°C.
Both fragments were cloned separately in pCR4 vector
with the TOPO TA kit (Invitrogen) and transformed in
XL1 Blue MRF’ electro-competent cells (Stratagene, La
Jolla, CA, USA) according to the manufacturer’s instruc-
tions. Then, the two plasmids were digested by NdeI and
NotI enzymes (New England Biolabs GmbH, Frankfurt am
Main, Germany). The rep gene enclosed between the NdeI
and NotI sites was ligated in the plasmid containing the
PCV-2a genome and digested by the same enzymes. The
ligation mix was subsequently transformed in XL1 Blue
MRF’ electro-competent cells.
T h eP C V - 2 bD N Ac l o n ew a sc o n s t r u c t e df r o mt h e
tandem infectious DNA clone already constructed and
characterized [21]. A primer pair, PCV-2b forward and
reverse primers (Table 1), was designed in the rep gene
to amplify by PCR a 1.5 PCV-2b DNA clone containing
only one copy of the cap gene. The PCR reaction mix
included 0.2 mM of dNTP mix, 0.2 μM of each primer,
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High Fidelity (Invitrogen) and its buffer to 1X in the
final concentration. The PCR reaction was composed of
a first denaturing step of 2 min at 94°C, then 30 amplifi-
cation cycles with one denaturing step of 30 s at 94°C,
an annealing step of 30 s at 56.3°C and an elongation
step of 2 min at 72°C; and finally an elongation step of
10 min at 72°C. The fragment of 1.5 genome copy was
purified on 1% agarose gel with the Ultrafree DA kit
(Millipore, Bedford, MA, USA) and then cloned in the
pCR4 vector, which was transformed in XL1 Blue MRF’
cells.
T h ei n t e g r i t yo ft h e1 . 5c o p i e so ft h eP C V - 2 aa n d
PCV-2b genomes in each parental DNA clone was con-
firmed by sequencing.
Construction of the PCV-2 mutants by inversion of the
two genogroup motifs
The sequence of each parental DNA clone was submitted
as template for design primers on the QuickChange
design program [23]. According to the manufacturer’s
instructions, mutagenesis was performed in two steps
because of the primer length. For each mutant, two pairs
of primers were designed (Table 1).
The primers used to mutate the PCV-2a DNA clone
were PCV-2a/(SNPISI) forward and reverse first and then
the PCV-2a/motif 2b forward and reverse. To mutate the
genogroup motif in the PCV-2b DNA clone, the primers
P C V - 2 b / ( T N K R S V )f o r w a r da n dr e v e r s ea n dP C V - 2 b /
motif 2a forward and reverse were used. All the mutagen-
esis reactions were carried out with the QuickChange II
XL mutagenesis kit (Stratagene), with some modifications.
Pfu Ultra HF DNA polymerase was replaced in the PCR
mix by Pfu Turbo DNA polymerase. The PCR protocol
was also optimized: the first denaturing step was extended
to 2 min at 95°C; then the 18 amplification cycles with one
denaturing step of 1 min at 95°C, an annealing step of 50 s
at 60°C and an elongation step of 6.5 min at 68°C; and
finally an elongation step of 10 min at 68°C. The PCR pro-
duct was digested with DpnI enzyme for one hour, and
4 μL of the digested PCR product was transformed in XL-
10 Gold chemically competent cells according to the man-
ufacturer instructions. Each mutant DNA clone was
checked by sequencing the 1.5 copies of the insert.
In vitro transfection
Eighty-percent confluent PK15 cells, seeded in six-well
plates, were transfected with 1 μgo fe a c hc l o n eD N A
using Lipofectamine LTX reagent (Invitrogen) according
to the manufacturer’s instructions. Twenty-four hours
post-transfection, supernatants were harvested and
stored at -80°C until virus titration. Cells were fixed
with 80% ice-cold acetone for 10 min at -20°C and
stored for the immunoperoxydase monolayer assay
(IPMA) at -20°C. Cells expressing the capsid of each
parental clone and of each mutant clone were revealed
by IPMA with polyclonal anti-PCV-2b antibody using a
previously described protocol [21]. Infectivity of both
parental and mutant clones was assessed by infecting
fresh PK15 cells with the transfection supernatants. Pro-
duction of infectious virus was assessed by IPMA, which
was specifically used to detect the viral capsid.
In vivo experimental trial
Research grade plasmid DNA (endotoxin ≤ 100 E.U./mg
DNA) from the four constructions was produced at a con-
centration of 0.5 mg/mL by Plasmid Factory (Bielefield,
Germany). For the trial, each DNA suspension was diluted
Table 1 Primers used to produce PCV-2 DNA clones
Primer name Primer sequence 5’-3’ Primer purpose
PCV-2a short forward AAGTATTACCAGCGCACTTC Amplification
PCV-2a short reverse ACCATTACGAAGTGATAAAA Amplification
PCV-2a long forward CCATGCCCTGAATTTCCATA Amplification
PCV-2a long reverse CCGTGGATTGTTCTGTAGCA Amplification
PCV-2b forward ACAACGGAGTGACCTGTCTA Amplification
PCV-2b reverse ACCATTACGAAGTGATAAAA Amplification
PCV-2a/(SNPISI) forward CCCCGGGAGGGGGGAGCAACCCAATCTCTATACCCTTT Mutation
PCV-2a/(SNPISI) reverse AAAGGGTATAGAGATTGGGTTGCTCCCCCCTCCCGGGG Mutation
PCV-2a/motif 2b forward GGGAGGGGGGAGCAACCCAAGGTCTGTACCCTTTGAATAC Mutation
PCV-2a/motif 2b reverse GTATTCAAAGGGTACAGACCTTGGGTTGCTCCCCCCTCCC Mutation
PCV-2b/(TNKRSV) forward CTTCCCCCAGGAGGGGGCACGAACAAGCGCTCTGTGCCCTTTGAA Mutation
PCV-2b/(TNKRSV) reverse TTCAAAGGGCACAGAGCGCTTGTTCGTGCCCCCTCCTGGGGGAAG Mutation
PCV-2b/motif 2a forward CCCAGGAGGGGGCACGAACAAGATCTCTATACCCTTTGAATACTACAGAATAA Mutation
PCV-2b/motif 2a reverse TTATTCTGTAGTATTCAAAGGGTATAGAGATCTTGTTCGTGCCCCCTCCTGGG Mutation
Mutations introduced in the primers are in bold and underlined.
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Buffer Saline (DPBS) (Sigma Aldrich, Lyon, France).
Five-week-old specific-pathogen-free (SPF) piglets,
from the Anses SPF herd, were used. The SPF piglets
were free from porcine circovirus type 1 and 2 (no
DNA and no PCV-antibodies detected), virus of African
swine fever and classical swine fever, virus of bovine
viral diarrhea, Border disease virus, Aujeszky’s disease
virus, parvovirus, porcine reproductive and respiratory
syndrome virus, swine influenza virus, virus of transmis-
sible gastro-enteritis, porcine respiratory coronavirus,
M. hyopneumoniae, P. multocida, B. bronchiseptica,
A. pleuropneumonia, H. parasuis, S. suis, T. hyodysenter-
iae. The experiment was performed in accordance with
EU and French regulations on animal experimentation.
Forty piglets were separated into six groups. Two
groups of four piglets (groups 1 and 2) were assigned as
controls and housed in the same room but in separate
units. The four other groups (groups 3, 4, 5 and 6) were
composed of eight piglets each and located in four sepa-
rate rooms. Piglets of each group received 400 μgo f
DNA from the parental or mutant DNA clones by intra-
muscular (IM) route in both sides of the neck. All piglets,
except those in group 1, were immunostimulated at
3 days post transfection (dpt) with 1.8 mg of keyhole lim-
pet hemocyanin (KLH) (Sigma Aldrich) and at 8 dpt with
0.9 mg of KLH (Sigma Aldrich) emulsified in incomplete
Freund’s adjuvant (Sigma Aldrich) in four injections
(both sides of the neck and hips) by IM route. Rectal
temperatures and clinical signs were recorded daily and
weights weekly. Blood samples were taken before DNA
inoculation and every week throughout the trial. All the
piglets were euthanized in the 5
th week post-transfection
by anesthesia followed by exsanguination. Necropsies
were performed and tissue samples (tracheobronchial,
mesenteric, axillary and inguinal lymph nodes; tonsils,
lung, spleen, liver and ileum) were collected and stored
at -80°C for laboratory investigations or in formol for
histopathology.
Macroscopic lesions, histopathology and immuno-
histochemistry
At necropsy, the macroscopic lesions were assessed. Enlar-
gement of lymph nodes was blinded scored by two per-
sons from 0 (no lesions) to 3 (severely enlarged and
congested). After scoring, macroscopic lesion means for
tracheo-bronchial lymph nodes were calculated per group.
Samples from tracheo-bronchial and inguinal lymph
nodes, tonsils, lung and liver were fixed in formalin for
histological examination. The microscopic lesions were
assessed on haemalun-eosin-safranin stained tissue sec-
tion. The microlesions were assessed by a person not
aware of the treatment received by the piglets, in lym-
phoid organs (represented by lymphocyte depletion and
presence of inflammation) and in the lungs (presence of
interstitial pneumonia) and each scored from absence
(0) to severe (3). Then the score means per group were
calculated using the microlesion score in the tracheo-
bronchial lymph nodes, inguinal lymph nodes and the
lungs. The presence of PCV-2 antigens was detected by
immunochemistry on fixed tissue sections (tracheobron-
chial and inguinal lymph nodes, tonsils, lung and liver)
as previously described [21] using a rabbit anti-PCV-2b
polyclonal serum.
PCV-2 serology
PCV-2 antibodies were detected in all collected sera
using a PCV-2 capsid protein-based Enzyme-Linked
Immunosorbent Assay (ELISA) as previously described
[24]. Results were expressed as the mean OD ratio
obtained between a control (well coated with GST pro-
tein) and sample (well coated with ORF2 of PCV-2
f u s e dw i t ht h eG S T )a n dw e r ec o n s i d e r e da sp o s i t i v e
when the OD ratio exceeded 1.5.
PCV-2 quantitative PCR
Two hundred milligrams of each tissue sample were
homogenized in phosphate buffer saline (PBS) using the
mixer mill MM301 (Retsch, Haan, Germany). Virus
DNA was extracted from 200 μL of serum with the
Wizard SV96 Genomic DNA Purification system (Pro-
mega, Madison, WI, USA) or from 80 μL of tissue
homogenate with the DNeasy tissue kit (Qiagen, Hilden,
Germany) according to the manufacturers’ recommen-
dations. Following the DNA extraction step, PCV-2 gen-
omes were quantified by a previously described PCV-2
TaqMan real-time PCR assay based on the amplification
of a PCV-2a and PCV-2b genomic target in the capsid
gene at 54 and 60°C [21].
Viral load titrations in organs
PCV-2 titration was assessed by IPMA following a pro-
tocol previously described [21] using a PCV-2b specific
polyclonal swine serum. The viral titers of the tonsils,
tracheobronchial and inguinal lymph nodes were deter-
mined by 10-fold serial dilutions according to Kaerber’s
method [25].
Sequencing of viral genomes detected in infected pigs
In order to check whether reversion events had occurred
in the pigs during the trial, sequencing analyses were
assessed. The viral genome was amplified from viral
DNA extracted from lymph nodes and sequenced.
Statistical analysis
PCV-2 antibody responses, lesion scores and infectious
PCV-2 titers were analyzed by the nonparametric Mann
and Whitney U-test using the SYSTAT 9 computer
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PCV-2 genomic loads in serum were statistically ana-
lyzed using an adapted method which associates a
Bernoulli model for the zero values and a log normal
model for the positive values [26].
Nucleotide sequence accession number
The complete genomic sequence of the PCV-2a isolate
reported in this paper has been deposited with the Gen-
Bank database under accession number HM623754.
Results
The parental and mutant DNA clones are infectious in
vitro
At 24 h post-transfection of PK15 cells, the capsid pro-
tein was detected by IPMA for the four constructions,
confirming that both PCV-2 parental and mutant DNA
clones were able to produce viral proteins (data not
shown). The ability of parental and mutant clones to
generate infectious virus was assessed by infecting fresh
PK15 with the supernatants of these transfected cells.
The cells infected with supernatants of both PCV-2 par-
ental clones showed PCV-2 antigens in their nucleus
(Figures 1A and 1B). Supernatants recovered from PK15
cells transfected with the mutant clones allowed the
infection of fresh PK15 cells as evidenced by the IPMA-
positive cells (Figures 1C and 1D). Thus, parental and
capsid mutant clones were infectious in vitro and able
to produce viral infectious particles.
Clinical signs, macroscopic findings
One piglet from the PCV-2b group 4 died on 16 dpt
due to bladder perforation.
In the control group 1, no hyperthermia (temperature >
40°C) was detected during the trial. In the immunostimu-
lated control group 2 and in the PCV-2a transfected
group 3, two pigs presented one day of hyperthermia
between 8 and 14 dpt. At the same time, the number of
piglets with hyperthermia as well as its duration
increased in the three other transfected groups (5 days
for 4/8 pigs in PCV-2b group 4, 3 days for 3/8 pigs in
PCV-2a/motif 2b group 5 and 4 days for 4/8 pigs in
PCV-2b/motif 2a group 6).
Regarding relative daily weight gain (rDWG) no differ-
ences between any groups were observed (data not
shown).
In the non-immunostimulated control group 1, no gross
lesions were observed at necropsies. Macrolesion intensity
was recorded and score averages were determined. The
macrolesions of the tracheobronchial (TB) lymph nodes
were significantly more severe in the PCV-2a group 3
(mean of 1.375) and the PCV-2b group 4 (mean of 1.5) (p
< 0.05) than in the control groups (0 and 0.625 in average
i ng r o u p1a n d2r e s p e c t i v e l y )a n dt h a ni nt h eP C V - 2 a /
motif 2b group (0.875 in average) (Table 2). In the PCV-
2b/motif 2a, the TB lymph nodes were more enlarged
(mean of 0.875) than those in the control groups and in
the PCV-2a/motif 2b group, but less than those in PCV-2a
and PCV-2b parental groups. However, these last differ-
ences were not statistically representative.
Microlesions and detection of antigens in lesions
Histopathological analyses revealed no microscopic
lesions in the control animals. The immunostimulation
caused histopathological lesions such as moderate inter-
stitial pneumonia and presence of abundant eosinophils
in lymphoid organs in two immunostimulated pigs.
Nevertheless the microlesions in this group (score mean
of 0.625) were significantly weaker than those in the
four transfected groups (Table 2). The more serious
microlesions consisting of a severe interstitial pneumo-
nia, were observed in the lungs of two pigs transfected
with the PCV-2b clone and in one pig transfected with
the PCV-2b/motif 2a clone. In the lymphoid organs,
moderate lymphocyte depletions were found in 2/8 pigs
transfected with PCV-2a, 6/8 transfected with PCV-2b,
2/8 transfected with PCV-2a/motif 2b and 4/8 with
PCV-2b/motif 2a. The means of microlesion score in
the four transfected groups were higher than in the two
control groups and equal to 1.125, 1.5, 1.09 and 1.34 in
respectively PCV-2a, PCV-2b, PCV-2a/motif 2b and
PCV-2b/motif 2a groups (Table 2).
The presence of viral antigens was assessed by IHC in
the organs of all animals. Viral antigens were neither
detected in any animals from the two control groups 1
and 2 nor in the animals inoculated with one mutant,
the PCV-2a/motif 2b clone. Conversely, most of the pigs
that received the two parental clones and the second
mutant, PCV-2b/motif 2a, were found positive by IHC.
Seroconversion
No seroconversion was detected in the two control
groups during the trial (Table 3). The first seroconver-
sion was detected at 21 dpt in the groups inoculated
with the PCV-2 parental clones (5/8 positive piglets in
t h eP C V - 2 ag r o u p3a n d6 / 7i nt h eP C V - 2 bg r o u p
4) and with the PCV-2b/motif 2a clone (7/8 piglet in
group 6). A discrepancy was noticed thereafter. At
28 dpt, all piglets in the PCV-2b and PCV-2b/motif 2a
inoculated groups 3 and 6 were seropositive, while the
eight PCV-2a inoculated piglets were seropositive one
week later at 35 dpt. These three groups 3, 4 and 6
were not statistically different. In contrast, piglets inocu-
lated with the PCV-2a/motif 2b mutant remained sero-
negative throughout the trial (p < 0.05 when compared
to the other transfected groups).
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Figure 1 Detection of the capsid after infection with supernatants of transfection of the four constructions. The capsid protein was
detected with an anti-PCV-2b serum confirming that both parental and mutant clones were infectious. 1A) PK15 cells infected with PCV-2a, 1B)
PK15 cells infected with PCV-2b, 1C) PK15 cells infected with PCV-2a/motif 2b, 1D) PK15 cells infected with PCV-2b/motif 2a and 1E) Mock-
infected PK15 cells. Magnification: ×40.
Allemandou et al. Veterinary Research 2011, 42:54
http://www.veterinaryresearch.org/content/42/1/54
Page 6 of 13Genomic viral load in sera
Detection of viral genomes in the control groups 1 and
2 remained negative throughout the trial (data not
shown). Viral genomes were detected first in the group
4 (PCV-2b) at 14 dpt in all piglets, with an average of
10
6.8 genome copies/mL of serum (Figure 2B). Then, the
load remains constant until the end of the trial. In the
group 3 (PCV-2a) and group 6 (PCV-2b/motif 2a),
genomic viral loads were detected in all piglets at 14 dpt
with mean of 10
6.8 genome copies/mL of serum in
g r o u p3a n do f1 0
6 copies/mL in group 6 (Figure 2A
and 2D). Compared to the group 4 (PCV-2b), the
expression of the viral genome decreased more rapidly
in the PCV-2b/motif 2a and PCV-2a groups (p <0 . 0 5
with the PCV-2b group). In the group 3 (PCV-2a), three
pigs positive in sera became negative at the end of the
trial for the detection of viral genomes. In the group 6
(PCV-2b/motif 2a), two pigs were negative at 21 dpt
and until the end and another pig presented no genomic
load in serum at the end. In group 5, no genomic viral
load was detected in any piglet inoculated with the
PCV-2a/motif 2b mutant (Figure 2C) (p <0 . 0 5w i t ht h e
three other transfected groups).
Genomic viral loads and viral titers in organs
Neither genomic viral load nor infectious particles
were found in the tissue of the two control groups
(data not shown). Piglets that received PCV-2b DNA
had viral genomes in their organs with 10
10.6 gen-
ome copies/g of tissue on average (Figure 3A). This
group 4 was significantly different from the three
others (p < 0.05). The groups inoculated with PCV-
2a and PCV-2b/motif 2a DNA showed lower geno-
mic loads with respectively an average of 10
10.7 and
10
9.4 genome copies/g of tissue (Figure 3A). These
three groups differed significantly from the PCV-2a/
m o t i f2 bg r o u p5p r e s e n t i n gam e a no f1 0
6.2 genome
copies/g of tissue.
The infectious viral titers determined in all groups had
similar profiles to the genomic loads. The highest titer was
found in the PCV-2b group with 10
4.6 TCID50/g of tissue.
However, the difference with the mean of infectious titers
in the groups inoculated with PCV-2a and PCV-2b/motif
2a (respectively 10
4.4 and 10
3.96 TCID50/g of tissue) was
n o ts i g n i f i c a n t( F i g u r e3 B ) .T h el o w e s tv i r a ll o a dw a s
determined in the organs of PCV-2a/motif 2b inoculated
piglets with an average of 10
2.74 TCID50/g of tissue which
Table 2 Score means of the macrolesions observed for the tracheobronchial (TB) lymph nodes and of the microlesions
observed for in TB and inguinal lymph nodes and lungs
Groups Number of animals presenting TB lymph node lesions and score
means
Score means of the
microlesions
Group 1: Control 0/4
0
a
0
a
Group 2: Control + immunostimulation ¾
0.625
a
0.625
a
Group 3: PCV2-a + immunostimulation 8/8
1.375
b
1.125
b
Group 4: PCV2-b + immunostimulation 8/8
1.5
b
1.5
b
Group 5: PCV-2a/motif 2b +
immunostimulation
4/8
0.625
a
1.09
b
Group 6: PCV-2b/motif 2a +
immunostimulation
6/8
0.875
a, b
1.34
b
Macrolesions in TB lymph nodes were scored as follows: 0 for no lesions, 1 for mild hypertrophy, 2 for moderate hypertrophy and congestion and 3 for severe
hypertrophy and congestion. In the same way, microscopic lesions observed in lymphoid organs (lymphocyte depletion in TB and inguinal lymph nodes) and in
lungs (interstitial pneumonia) were scored. Score means were then calculated and subjected to statistical analysis, with a and b indicating statistic difference
(
aand
b for p < 0.05).
Table 3 Seroconversion to PCV-2 assessed by ELISA
-1 dpt 7 dpt 14 dpt 21 dpt 28 dpt 35 dpt
Group 1: Control 0/4 0/4 0/4 0/4 0/4 0/4
Group 2: Control + immunostimulation 0/4 0/4 0/4 0/4 0/4 0/4
Group 3: PCV-2a + immunostimulation 0/8 0/8 0/8 5/8
a 7/8
a 8/8
a
Group 4: PCV-2b + immunostimulation 0/8 0/8 0/8 6/7
a 7/7
a 7/7
a
Group 5: PCV-2a/motif 2b + immunostimulation 0/8 0/8 0/8 0/8
b 0/8
b 0/8
b
Group 6: PCV-2b/motif 2a + immunostimulation 0/8 0/8 0/8 7/8
a 8/8
a 8/8
a
(
a and
b for p < 0.05).
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Page 7 of 13was significantly different from the three other group ( p <
0.05) (Figure 3B).
Sequencing results
No reversion in the cap gene was detected on the two
fragments amplified from the DNA recovered from tis-
sue infected by the two mutants (data not shown).
Discussion
This work was carried out in order to establish whether
two isolates of PCV-2, each representing one major
PCV-2 genogroup, present different characteristics and
virulence. The genogroup motif of the capsid protein was
previously suspect to be a determinant of virulence. Here,
we elucidate the implication of this motif in the character-
istics of strains and mutants, and consequently in their
v i r u l e n c eb yc o n s t r u c t i n gt w op a r e n t a lc l o n e sa n dt w o
mutant clones with their genogroup motif swapped.
In vitro, capsid proteins were detected in cells trans-
fected by the four constructions 24 h post-transfection,
providing evidence that the introduced mutations did not
affect protein expression as described previously [27,28].
Furthermore, capsid proteins were also produced by cells
infected with the transfection supernatants. This result
demonstrated that transfection by the parental and
mutant clones were followed by the production of infec-
tious viral particles, presenting homologies with several
other PCV-2 DNA clones [21,22,27].
Infectious DNA clone strategy was developed to produce
pure and standardized inoculum because PCV-2 virus
stocks with high titers were hard to produce in vitro. In
this study, the use of DNA clones for inoculation instead
of viruses allowed to standardize inoculum with the same
number of DNA copies injected. Immunostimulation with
KLH emulsified in ICFA was used to trigger clinical signs,
knowing that this protocol induced some microlesions
such as mild to moderate interstitial pneumonia and
eosinophil infiltration. However, in the groups where
immunostimulation was associated with PCV-2, the
microlesions were more pronounced than in those of the
immunostimulated group.
In vivo, pigs transfected with both parental clones devel-
oped sub-clinical infections. In spite of this, the genomic
loads in serum and in the lymphoid organs were signifi-
cantly higher in the pigs transfected with the PCV-2b clone
than those transfected with the PCV-2a clone. Results of
this study showed that the PCV-2b infectious clone present
different characteristics than the PCV-2a one.
The virulence of both isolates has already been studied
in several experiments. Differences between the two
2A  2B   
2C  2D 
Figure 2 Genomic viral load of PCV-2 in sera of the four groups respectively inoculated with PCV-2a (2A), PCV-2b (2B), PCV-2a/
motif2b (2C) and PCV-2b/motif 2a (2D). Results were expressed in log10 of viral genome copies per mL of serum, each point representing
the genomic load in the serum of one piglet. The number indicated at each time represented the mean of genomic viral loads.
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eight months without immunostimulation. Moreover,
PMWS was reproduced in SPF piglets with the same
PCV-2b isolate using the virus without immunostimula-
t i o n[ 2 9 ] .W ea l s op r e v i o u s l yd e m o n s t r a t e dt h a ta
PCV-2b infectious clone (the same isolate as in this
s t u d y )w a si n f e c t i o u si nv i v oa n dw a sa b l et ot r i g g e r
clinical PMWS in an SPF piglet when PCV-2b clone
transfection and immunostimulation were combined
[21]. In this previous work, the PCV-2b genomic load
3A 
 
3B 
Figure 3 Averages of genomic PCV-2 viral load (3A) and infectious viral titers (3B) in tissue samples at the end of the trial (tonsils,
tracheobrochial and inguinal lymph nodes) in groups transfected with PCV-2a, PCV-2b, PCV-2a/motif 2b and PCV-2b/motif 2a (a, b, c
and d with p < 0.05).
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piglet reached an average of 10
14 genome copies/g of
tissue at 32 dpt. In our present study, the maximum
genomic load in organs was 10
10.6 genome copies/g of
tissue at 35 dpt in a pig inoculated with the PCV-2b
clone which is below the PMWS diagnosis threshold of
10
11 genome copies/g of tissue proposed by Blanchard
et al. [24]. The differences found between these two stu-
dies could be explained by the quantity of DNA injected
in pigs. In contrast, the PCV-2a infectious clone was not
previously tested for virulence itself, although the virus
failed to induce PMWS in piglets, while it was recovered
from a diseased piglet [20]. Thus the two parental
clones PCV-2a and PCV-2b showed differences in
experimental conditions similar to the infectious virus.
On the other hand, difference in virulence could also be
observed between isolates of the same PCV-2a gen-
ogroup [30]. Indeed, two PCV-2a isolates (Genbank
accession numbers DQ397521 and AF264042) exhibited
differences in microlesions, in genomic viral loads in
sera and in seroconversion. The conclusion stated that
the AF264042 strain was more virulent than the other
one even if the AF264042 PCV-2a induced sub-clinical
infections [30,31]. These two strains presented nine
amino acids difference in their Cap proteins and two in
their Rep proteins. A study has also demonstrated that
only two amino acid differences in the Cap protein at
positions 110 and 191 led to difference in PCV-2 viru-
lence in vivo [32]. In our study, the Cap proteins of
PCV-2a and PCV-2b had twenty amino acid differences
(Figure 4) and the Rep proteins one amino acid (at posi-
tion 32). The two parental Cap proteins differed by their
motif specific of the genogroup but also in amino acids
59, 75, 131, 206 and 232 that were amino acid changes
between the two PCV-2a DQ397521 and AF264042 that
previously showed differences in virulence [31]. Here
the two parental clone Cap also displayed a change in
amino acid 191 that was one of the amino acid found
responsible for virulence attenuation [32]. Thus there
were several differences that could be involved in the
different characteristics of PCV-2a and PCV-2b.
In vivo characterization of the two mutants was also
carried out in order to determine if the genogroup motif
was involved in the virulence mechanism of PCV-2. The
two mutant clones induced sub-clinical infection. Some
of the parameters examined to define PCV-2 virulence
mechanism (genomic loads in serum and in organs)
were weakened in piglets inoculated with the PCV-2b/
motif 2a mutant in comparison to those inoculated with
t h eP C V - 2 bc l o n e .T h i sm u t a n tc l o n ew a si n f e c t i o u si n
vivo and allowed the development of a PCV-2 immuno-
genic response. Similarly, the PCV-2a/motif 2b mutant
clone presented a decrease in virulence relative to its
parent, the PCV-2a clone. However, the introduction of
the capsid motif specific to the potentially more virulent
P C V - 2 bg e n o g r o u pd i dn o tc o n f e rh i g h e rv i r u l e n c e
properties to the recipient PCV-2a virus. On the con-
trary, slight genomic loads and infectious titers in
organs were revealed, explaining that no seroconversion,
no genome copies in the serum and no viral antigens in
the lesions were detected for PCV-2a/motif 2b inocu-
lated group. Macroscopic lesions were also less severe in
pigs transfected with this mutant than in those trans-
fected by the PCV-2a parental clone. All these results
showed that the PCV-2a/motif 2b mutant clone had a
virulence attenuated compared to its parent, the PCV-2a
clone.
PCV-2 genomic loads found in the organs of the PCV-
2a/motif 2b transfected piglets were not remnants of
plasmid input. Indeed, a previous study in our labora-
tory showed that after injection by intra-muscular route
of plasmid DNA in SPF pigs, that the plasmid DNA was
detected until 28 dpt in the injected muscle and 17 dpt
in the draining pre-scapular lymph nodes. In other
organs such as the liver, the spleen and the lungs,
injected plasmid DNA was present until 1 dpt in few
quantity [33]. In our study, piglets were euthanized after
35 dpt, later than the last detection of plasmids in the
previous experiment. These results confirmed that the
PCV-2 genomes detected in organs were viral DNA and
not input plasmid DNA.
The quantitative PCR results in organs revealed that
the replication is not impaired either for the two paren-
tal clones or for the two mutants. The genomic loads
were lower in the organs of the pigs transfected with
the mutant clones than those of the pigs transfected
with the parental clones and in the organs of the PCV-
2a transfected pigs compared to those transfected with
PCV-2b. This demonstrated that the replication effi-
ciency could be different between parental strains and
between both parental clones and mutants. One hypoth-
esis to explain this is a differential regulation of the
replication step. It was previously showed that the regu-
lation of replication was controlled by the Rep and its
own promoter for porcine circovirus [7]. In our study,
the Rep and Rep’ proteins of the two parental clones
had only one amino acid difference. This amino acid
was outside of the three motives implicated in the Rep
functions [34,35] and hence might not explain a differ-
ence in replication. Nevertheless, in some Gemini-
viruses, the absence or inactivation of the Cap protein
led to reduced accumulation of single-stranded DNA
associated with an increase in the level of double-
stranded DNA replicative forms [36,37]. It has been also
reported that the Cap protein of the mung bean yellow
mosaic India virus, a geminivirus, might have a role in
controlling the viral replication and thus the copy num-
ber of viral DNA. Indeed, the interaction of its Cap and
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of the Rep and not the Rep ATPase activity [38].
Therefore, as Cap and Rep proteins of PCV-2 interacts
[39], PCV-2 capsid protein might be implicated in the
regulation of replication like for the Geminiviruses, and
amino acid difference in Cap between the two parental
isolates could explain difference in genomic loads.
The hypothesis is that the PCV-2b capsid protein
might less interact with the PCV-2b Rep compared to
the PCV-2a Cap protein with the PCV-2a Rep. In this
case, the PCV-2a Cap protein might lead to the most
effective control of replication. For PCV-2b, the Cap
protein with less interaction with the Rep could result
to enhanced replication and accumulation of double-
stranded DNA, like for the Geminiviruses [37]. In the
same way, the introduction of the PCV-2a motif in the
PCV-2b backbone (PCV-2b/motif 2a clone) induced a
decrease of viral DNA in organs compared to the PCV-
2b and PCV-2a groups. This suggests that the motif
specific of genogroup may be involved in the control
of replication. However, on the other hand, the
introduction of PCV-2b motif in the PCV-2a backbone
(PCV-2a/motif 2b group) led to a decrease of genome
copies in organs compared to the PCV-2a but also to a
decrease of the produced infectious particles. These lat-
ter results showed that the genogroup motif could be
involved in the replication regulation but not solely. In
this study, the PCV-2a/motif 2b mutant presented an
attenuation of virulence compared to its parent the
PCV-2a. The swap of the genogroup motif i.e. four
amino acids mutated in PCV-2a, might have generated a
defective virus. But the opposite with the introduction
of 4 mutations in the PCV-2b capsid protein did not
cause the same effect. It has been shown for PCV-2a
that only two amino acid mutations in the capsid pro-
tein induced virulence attenuation [32]. Consequently,
we can assume that the capsid protein of PCV-2 does
not support a lot of variation. The genogroup motif is
an important determinant for characteristics and viru-
lence of isolates. The results of the two mutants of this
study demonstrated that the capsid background of this
motif is also strongly implicated in these mechanisms.
            8                      30                     
PCV-2a Cap      (1)  MTYPRRRFRR RRHRPRSHLG QILRRRPWLL HPRHRYRWRR KNGIFNTRLS
PCV-2a/motif 2b Cap     (1)  MTYPRRRFRR RRHRPRSHLG QILRRRPWLL HPRHRYRWRR KNGIFNTRLS
PCV-2b Cap      (1)  MTYPRRRYRR RRHRPRSHLG QILRRRPWLV HPRHRYRWRR KNGIFNTRLS
PCV-2b/motif 2a Cap  (1)  MTYPRRRYRR RRHRPRSHLG QILRRRPWLV HPRHRYRWRR KNGIFNTRLS
                       
             59                75/77/80   86/88/89/91      
PCV-2a Cap        (51) RTFGYTVKAT TVRTPSWAVD MMRFKIDDFV PPGGGTNKIS IPFEYYRIRK
PCV-2a/motif 2b Cap   (51) RTFGYTVKAT TVRTPSWAVD MMRFKIDDFV PPGGGSNPRS VPFEYYRIRK
PCV-2b Cap       (51) RTFGYTVKRT TVRTPSWAVD MMRFNINDFL PPGGGSNPRS VPFEYYRIRK
PCV-2b/motif 2a Cap  (51) RTFGYTVKRT TVRTPSWAVD MMRFNINDFL PPGGGTNKIS IPFEYYRIRK
     *      *        **       
                     131     140/141/143           
PCV-2a Cap       (101)VKVEFWPCSP ITQGDRGVGS TAVILDDNFF PKSTALTYDP YVNYSSRHTI
PCV-2a/motif 2b Cap   (101)VKVEFWPCSP ITQGDRGVGS TAVILDDNFF PKSTALTYDP YVNYSSRHTI
PCV-2b Cap       (101)VKVEFWPCSP ITQGDRGVGS SAVILDDNFV TKATALTYDP YVNYSSRHTI
PCV-2b/motif 2a Cap  (101)VKVEFWPCSP ITQGDRGVGS SAVILDDNFV TKATALTYDP YVNYSSRHTI
                 *   *     
151                                     190/191     
PCV-2a Cap       (151)PQPFSYHSRY FTPKPVLDST IDYFQPNNKR NQLWLRLQTS ANVDHVGLGT
PCV-2a/motif 2b Cap   (151)PQPFSYHSRY FTPKPVLDST IDYFQPNNKR NQLWLRLQTS ANVDHVGLGT
PCV-2b Cap       (151)TQPFSYHSRY FTPKPVLDST IDYFQPNNKR NQLWLRLQTA GNVDHVGLGT
PCV-2b/motif 2a Cap   (151)TQPFSYHSRY FTPKPVLDST IDYFQPNNKR NQLWLRLQTA GNVDHVGLGT
*        
    206/210                      232 
PCV-2a Cap       (201)AFENSKYDQD YNIRVTMYVQ FREFNLKDPP LKP 
PCV-2a/motif 2b Cap   (201)AFENSKYDQD YNIRVTMYVQ FREFNLKDPP LKP 
PCV-2b Cap      (201)AFENSIYDQE YNIRVTMYVQ FREFNLKDPP LNP 
PCV-2b/motif 2a Cap   (201)AFENSIYDQE YNIRVTMYVQ FREFNLKDPP LNP 
*
Figure 4 Comparison of the capsid protein sequence of the two parental strains and of the two mutants. Differences in amino acids
between the two parental isolates are indicated in bold and underlined. The genogroup motif is highlighted in grey. Asterisk indicated the six
amino acid difference between two PCV-2 isolates showing difference in virulence [31] and the dot the two mutations responsible for
attenuation by Fenaux et al. [31].
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Page 11 of 13In conclusion, these results demonstrated that the
PCV-2b isolate presented different characteristics from
t h eP C V - 2 ai s o l a t ea n dt h ev i r u l e n c eo fP C V - 2s e e m e d
to involve the capsid and more particularly the gen-
ogroup motif and its background, but not only.
Acknowledgements
We would like to thank the U.S. National Pork Board (project NPB 08-268) for
providing funding, as well as Fort Dodge for donating the PCV-2a strain.
We also would like to thank the experimental unit of the Anses for their
help in the experimental trial.
Authors’ contributions
AA participated in the design of the study, carried out the construction of
the two infectious clones and of the two mutants, performed the clone
transfections, the clone sequencing, the PCV-2 quantitative PCR in the
organs and the statistical analysis, and drafted the manuscript. BG conceived
of the study, participated in its design and coordination, participated in the
in vivo trial and performed the virus titration in the organs. A-C N-H
participated in the in vivo experiment and carried out the PCV-2 quantitative
PCR in the serum and the PCV-2 ELISA. AK took care of the animals in the
facilities and participated in the in vivo trial. RC participated in the design of
the in vivo trial and coordinated it. AJ participated in the design of the study
and its coordination. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 21 September 2010 Accepted: 24 March 2011
Published: 24 March 2011
References
1. Tischer I, Rasch R, Tochtermann G: Characterization of papovavirus-and
picornavirus-like particles in permanent pig kidney cell lines. Zentralbl
Bakteriol Orig A 1974, 226:153-167.
2. Allan GM, McNeilly F, Cassidy JP, Reilly GA, Adair B, Ellis WA, McNulty MS:
Pathogenesis of porcine circovirus; experimental infections of colostrum
deprived piglets and examination of pig foetal material. Vet Microbiol
1995, 44:49-64.
3. Gillespie J, Opriessnig T, Meng XJ, Pelzer K, Buechner-Maxwell V: Porcine
circovirus type 2 and porcine circovirus-associated disease. J Vet Intern
Med 2009, 23:1151-1163.
4. Mankertz A, Domingo M, Folch JM, LeCann P, Jestin A, Segales J,
Chmielewicz B, Plana-Duran J, Soike D: Characterisation of PCV-2 isolates
from Spain, Germany and France. Virus Res 2000, 66:65-77.
5. Sorden SD: Update on porcine circovirus and postweaning multisystemic
wasting syndrome (PMWS). Swine Health and Production 2000, 8:133-136,
133-136.
6. Casadevall A, Pirofski LA: Host-pathogen interactions: redefining the basic
concepts of virulence and pathogenicity. Infect Immun 1999,
67:3703-3713.
7. Mankertz A, Caliskan R, Hattermann K, Hillenbrand B, Kurzendoerfer P,
Mueller B, Schmitt C, Steinfeldt T, Finsterbusch T: Molecular biology of
Porcine circovirus: analyses of gene expression and viral replication. Vet
Microbiol 2004, 98:81-88.
8. Nawagitgul P, Morozov I, Bolin SR, Harms PA, Sorden SD, Paul PS: Open
reading frame 2 of porcine circovirus type 2 encodes a major capsid
protein. J Gen Virol 2000, 81:2281-2287.
9. Juhan NM, LeRoith T, Opriessnig T, Meng XJ: The open reading frame 3
(ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus
infection but evidence of reduced pathogenicity is limited in pigs
infected by an ORF3-null PCV2 mutant. Virus Res 2009, 147:60-66.
10. Cheung AK, Lager KM, Kohutyuk OI, Vincent AL, Henry SC, Baker RB,
Rowland RR, Dunham AG: Detection of two porcine circovirus type 2
genotypic groups in United States swine herds. Arch Virol 2007,
152:1035-1044.
11. Olvera A, Cortey M, Segales J: Molecular evolution of porcine circovirus
type 2 genomes: phylogeny and clonality. Virology 2007, 357:175-185.
12. Gagnon CA, Tremblay D, Tijssen P, Venne MH, Houde A, Elahi SM: The
emergence of porcine circovirus 2b genotype (PCV-2b) in swine in
Canada. Can Vet J 2007, 48:811-819.
13. Wiederkehr DD, Sydler T, Buergi E, Haessig M, Zimmermann D, Pospischil A,
Brugnera E, Sidler X: A new emerging genotype subgroup within PCV-2b
dominates the PMWS epizooty in Switzerland. Vet Microbiol 2009,
136:27-35.
14. Cortey M, Pileri E, Sibila M, Pujols J, Balasch M, Plana J, Segales J: Genotypic
shift of porcine circovirus type 2 from PCV-2a to PCV-2b in Spain from
1985 to 2008. Vet J .
15. de Boisseson C, Beven V, Bigarre L, Thiery R, Rose N, Eveno E, Madec F,
Jestin A: Molecular characterization of Porcine circovirus type 2 isolates
from post-weaning multisystemic wasting syndrome-affected and non-
affected pigs. J Gen Virol 2004, 85:293-304.
16. Crowther RA, Berriman JA, Curran WL, Allan GM, Todd D: Comparison of
the structures of three circoviruses: chicken anemia virus, porcine
circovirus type 2, and beak and feather disease virus. J Virol 2003,
77:13036-13041.
17. Lekcharoensuk P, Morozov I, Paul PS, Thangthumniyom N, Wajjawalku W,
Meng XJ: Epitope mapping of the major capsid protein of type 2
porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J Virol 2004,
78:8135-8145.
18. Mahe D, Blanchard P, Truong C, Arnauld C, Le Cann P, Cariolet R, Madec F,
Albina E, Jestin A: Differential recognition of ORF2 protein from type 1
and type 2 porcine circoviruses and identification of immunorelevant
epitopes. J Gen Virol 2000, 81:1815-1824.
19. Lefebvre DJ, Costers S, Van Doorsselaere J, Misinzo G, Delputte PL,
Nauwynck HJ: Antigenic differences among porcine circovirus type 2
strains, as demonstrated by the use of monoclonal antibodies. J Gen
Virol 2008, 89:177-187.
20. Rovira A, Balasch M, Segales J, Garcia L, Plana-Duran J, Rosell C, Ellerbrok H,
Mankertz A, Domingo M: Experimental inoculation of conventional pigs
with porcine reproductive and respiratory syndrome virus and porcine
circovirus 2. J Virol 2002, 76:3232-3239.
21. Grasland B, Loizel C, Blanchard P, Oger A, Nignol AC, Bigarre L, Morvan H,
Cariolet R, Jestin A: Reproduction of PMWS in immunostimulated SPF
piglets transfected with infectious cloned genomic DNA of type 2
porcine circovirus. Vet Res 2005, 36:685-697.
22. Fenaux M, Halbur PG, Haqshenas G, Royer R, Thomas P, Nawagitgul P,
Gill M, Toth TE, Meng XJ: Cloned genomic DNA of type 2 porcine
circovirus is infectious when injected directly into the liver and lymph
nodes of pigs: characterization of clinical disease, virus distribution, and
pathologic lesions. J Virol 2002, 76:541-551.
23. Stratagene: QuickChange design program. [http://www.stratagene.com/
sdmdesigner/].
24. Blanchard P, Mahe D, Cariolet R, Truong C, Le Dimna M, Arnauld C, Rose N,
Eveno E, Albina E, Madec F, Jestin A: An ORF2 protein-based ELISA for
porcine circovirus type 2 antibodies in post-weaning multisystemic
wasting syndrome. Vet Microbiol 2003, 94:183-194.
25. Kaerber G: Beitrag zur kollectiven behandlung pharmakologischer.
Reihenversuche. Arch für Pharmakologie und Experimentelle Pathologie 1931,
162:480-483.
26. Rose N, Blanchard P, Cariolet R, Grasland B, Amenna N, Oger A, Durand B,
Balasch M, Jestin A, Madec F: Vaccination of porcine circovirus type 2
(PCV2)-infected sows against porcine Parvovirus (PPV) and Erysipelas:
effect on post-weaning multisystemic wasting syndrome (PMWS) and
on PCV2 genome load in the offspring. J Comp Pathol 2007, 136:133-144.
27. Cheung AK, Bolin SR: Kinetics of porcine circovirus type 2 replication.
Arch Virol 2002, 147:43-58.
28. Finsterbusch T, Steinfeldt T, Caliskan R, Mankertz A: Analysis of the
subcellular localization of the proteins Rep, Rep’ and Cap of porcine
circovirus type 1. Virology 2005, 343:36-46.
29. Albina E, Truong C, Hutet E, Blanchard P, Cariolet R, L’Hospitalier R, Mahe D,
Allee C, Morvan H, Amenna N, et al: An experimental model for post-
weaning multisystemic wasting syndrome (PMWS) in growing piglets.
J Comp Pathol 2001, 125:292-303.
30. Opriessnig T, Ramamoorthy S, Madson DM, Patterson AR, Pal N,
Carman S, Meng XJ, Halbur PG: Differences in virulence among porcine
circovirus type 2 isolates are unrelated to cluster type 2a or 2b and
prior infection provides heterologous protection. J Gen Virol 2008,
89:2482-2491.
Allemandou et al. Veterinary Research 2011, 42:54
http://www.veterinaryresearch.org/content/42/1/54
Page 12 of 1331. Opriessnig T, McKeown NE, Zhou EM, Meng XJ, Halbur PG: Genetic and
experimental comparison of porcine circovirus type 2 (PCV2) isolates
from cases with and without PCV2-associated lesions provides evidence
for differences in virulence. J Gen Virol 2006, 87:2923-2932.
32. Fenaux M, Opriessnig T, Halbur PG, Elvinger F, Meng XJ: Two amino acid
mutations in the capsid protein of type 2 porcine circovirus (PCV2)
enhanced PCV2 replication in vitro and attenuated the virus in vivo.
J Virol 2004, 78:13440-13446.
33. Gravier R, Dory D, Laurentie M, Bougeard S, Cariolet R, Jestin A: In vivo
tissue distribution and kinetics of a pseudorabies virus plasmid DNA
vaccine after intramuscular injection in swine. Vaccine 2007, 25:6930-6938.
34. Mankertz A, Mueller B, Steinfeldt T, Schmitt C, Finsterbusch T: New reporter
gene-based replication assay reveals exchangeability of replication
factors of porcine circovirus types 1 and 2. J Virol 2003, 77:9885-9893.
35. Vega-Rocha S, Byeon IJ, Gronenborn B, Gronenborn AM, Campos-Olivas R:
Solution structure, divalent metal and DNA binding of the endonuclease
domain from the replication initiation protein from porcine circovirus 2.
J Mol Biol 2007, 367:473-487.
36. Azzam O, Frazer J, de la Rosa D, Beaver JS, Ahlquist P, Maxwell DP: Whitefly
transmission and efficient ssDNA accumulation of bean golden mosaic
geminivirus require functional coat protein. Virology 1994, 204:289-296.
37. Padidam M, Beachy RN, Fauquet CM: A phage single-stranded DNA
(ssDNA) binding protein complements ssDNA accumulation of a
geminivirus and interferes with viral movement. J Virol 1999,
73:1609-1616.
38. Malik PS, Kumar V, Bagewadi B, Mukherjee SK: Interaction between coat
protein and replication initiation protein of Mung bean yellow mosaic
India virus might lead to control of viral DNA replication. Virology 2005,
337:273-283.
39. Timmusk S, Fossum C, Berg M: Porcine circovirus type 2 replicase binds
the capsid protein and an intermediate filament-like protein. J Gen Virol
2006, 87:3215-3223.
doi:10.1186/1297-9716-42-54
Cite this article as: Allemandou et al.: Modification of PCV-2 virulence by
substitution of the genogroup motif of the capsid protein. Veterinary
Research 2011 42:54.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Allemandou et al. Veterinary Research 2011, 42:54
http://www.veterinaryresearch.org/content/42/1/54
Page 13 of 13